Hi Hyper I was at the AGM and from what was said there I think they already have a agreement with the FDA on this maybe it’s not official yet but I am assuming it’s not far away . Apparently bile duct cancer is worse than pancreatic cancer and because there are a lot fewer cases I am assuming the big players are not to interested in spending 1/2 billion on trials to address it . Not to sure about Noddys assumption there is money to be made here as nothing was mentioned at the AGM . Hope his right though that in itself would drive the SP . The fact it’s not approved would probably mean anyone using it would need to fund it themselves as I can’t see health insurance companies stumping up the money .
OSL Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)